In this podcast, expert clinicians will discuss the mechanism of action of and clinical evidence for the use of soluble guanylate cyclase (sGC) modulators in heart failure with reduced ejection fraction (HFrEF).

In this podcast, expert clinicians will discuss the updated guideline recommendations for the management of heart failure with reduced ejection fraction (HFrEF) and worsening HF.

In this podcast, expert clinicians will discuss the burden of HFrEF and worsening HF.

In this podcast, expert clinicians will discuss evidence-based management of CV risk reduction.

Clinical Evidence for Omega-3 PUFAs for Managing CV Risk with Drs. Peter Toth and Pam Taub.

The Impact of Omega-3 PUFAs on CV Risk Reduction with Drs. Peter Toth and Amit Khera.

In this podcast, expert clinicians will discuss the role of inflammation in atherosclerosis.

In this podcast, expert clinicians will discuss management selection for embolic stroke with a PFO.

In this podcast, expert clinicians will discuss treatment options for embolic stroke due to a PFO.

In this podcast, expert clinicians will discuss the current guidelines for the management of embolic stroke with a PFO.

In this podcast, expert clinicians will discuss challenges in the diagnosis of embolic stroke with a PFO.

In this podcast, expert clinicians will share procedural pearls for PFO closure and important considerations to optimize patient outcomes.

In this podcast, expert clinicians will discuss management of patients with cryptogenic stroke as well as strategies for applying new guideline recommendations into practice.

In this podcast, expert clinicians will discuss the association between patent foramen ovale and stroke and review the current clinical data to support PFO closure.

In this podcast, expert clinicians will discuss strategies for classification and workup of cryptogenic stroke and PFO-associated stroke.

In this podcast, expert clinicians will discuss latest clinical evidence from cardiovascular outcomes trials and how reducing triglycerides for further reduces risk.

In this podcast, expert clinicians will discuss evidence regarding mitigating cardiovascular risk by LDL-C reduction.

In this podcast, expert clinicians will discuss secondary prevention and how to identify patients who may benefit from additional treatment to reduce CV risk.

In this podcast, expert clinicians discuss primary prevention as well as strategies for ASCVD risk assessment.

In this podcast, expert clinicians will discuss the potential use of sGC modulators in the management of patients with heart failure with reduced ejection fraction (HFrEF).